Topical application of glycyrrhizin preparation ameliorates experimentally induced colitis in rats
Authors:
- Shinichi OkamuraSOShinichi Okamura
- Yajing ZhangYZYajing Zhang
- Takashige MasuoTMTakashige Masuo
- Masatomo MoriMMMasatomo Mori
Open Access
- 1 January 2011
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 17 (17) , 2223-8
Abstract
To examine the efficacy of glycyrrhizin preparation (GL-p) in the treatment of a rat model of ulcerative colitis (UC). Experimental colitis was induced by oral administration of dextran sodium sulfate. Rats with colitis were intrarectally administered GL-p or saline. The extent of colitis was evaluated based on body weight gain, colon wet weight, and macroscopic damage score. The expression levels of pro-inflammatory cytokines and chemokines in the inflamed mucosa were measured by cytokine antibody array analysis. The effect of GL-p on myeloperoxidase (MPO) activity in the inflamed mucosa and purified enzyme was assayed. GL-p treatment significantly ameliorated the extent of colitis compared to sham treatment with saline. Cytokine antibody array analysis showed that GL-p treatment significantly decreased the expression levels of pro-inflammatory cytokines and chemokines, including interleukin (IL)-1β, IL-6, tumor necrosis factor-α, cytokine-induced neutrophil chemoattractant-2, and monocyte chemoattractant protein-1 in the inflamed mucosa. Furthermore, GL-p inhibited the oxidative activity of mucosal and purified MPO. GL-p enema has a therapeutic effect on experimental colitis in rats and may be useful in the treatment of UC.Keywords
This publication has 21 references indexed in Scilit:
- Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive CompoundsPhytotherapy Research, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- A Long-Term Glycyrrhizin Injection Therapy Reduces Hepatocellular Carcinogenesis Rate in Patients with Interferon-Resistant Active Chronic Hepatitis C: A Cohort Study of 1249 PatientsDigestive Diseases and Sciences, 2006
- Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitisWorld Journal of Gastroenterology, 2006
- Antibody array analysis of peripheral and blood cytokine levels in rats after masseter inflammationNeuroscience Letters, 2005
- INVOLVEMENT OF INTERLEUKIN-1 IN THE DEVELOPMENT OF ULCERATIVE COLITIS INDUCED BY DEXTRAN SULFATE SODIUM IN MICECytokine, 1998
- glycyrrhizin as a potential treatment for chronic hepatitis CAlimentary Pharmacology & Therapeutics, 1998
- The long term efficacy of glycyrrhizin in chronic hepatitis C patientsCancer, 1997
- Better quality of therapy with 5-ASA colonic foam in active ulcerative colitisDigestive Diseases and Sciences, 1993
- Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis.1991